updates on breast cancer treatment: exploring cdk4/6 inhibitors & endocrine therapy
Published 3 months ago • 11 plays • Length 11:00Download video MP4
Download video MP3
Similar videos
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
11:41
cdk4 6 inhibitors: changing the early breast cancer landscape
-
3:41
updates on cdk 4/6 inhibitors in metastatic breast cancer
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
6:05
cdk4/6 inhibitors & endocrine therapy: selecting a regimen
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
7:03
updates on cdk4/6 inhibitor therapy
-
6:15
breast cancer at esmo 2020: cdk4/6 inhibitors and checkpoint inhibitors
-
5:07
what is the role of cdk4/6 inhibitors in early breast cancer?
-
2:31
cdk4/6 inhibitors: a hot topic in breast cancer treatment
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
7:58
cdk 4/6 inhibitors: how are they used in metastatic breast cancer treatment?
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
4:35
cdk4/6 inhibitors & endocrine therapy: adverse events
-
8:42
hr mbc: treatment after progression on cdk4/6 inhibition